Long intergenic non-protein coding RNA 648 (LINC00648)

Long intergenic non-protein coding RNA 648 (LINC00648) is a long non-coding RNA (lncRNA) transcript that does not encode a protein, but plays regulatory roles in the cell[1][3][5]. It is significantly overexpressed in various cancers, including lung cancer, where high expression correlates with lymphatic metastasis, lower tumor differentiation, and reduced overall survival[1][2][4]. LINC00648 likely functions as a competing endogenous RNA (ceRNA), sequestering microRNAs and thereby modulating the expression of their target mRNAs. This regulatory function has implications in transcriptional regulation involving processes such as SMAD binding, RNA polymerase II activation, Hippo and MAPK signaling, and TGF-beta receptor pathways[1][2][4]. LINC00648 does not have a known direct interaction with drugs and is not itself considered a traditional drug target like a receptor or enzyme. However, its expression serves as a potential diagnostic and prognostic biomarker in cancer, particularly lung cancer[1][2][4].

Other names

LINC00648long intergenic non-protein coding RNA 648